This topic contains a solution. Click here to go to the answer

Author Question: It is acceptable to lose eye contact with the audience during the time when you are pointing toward ... (Read 85 times)

jrubin

  • Hero Member
  • *****
  • Posts: 552
It is acceptable to lose eye contact with the audience during the time when you are pointing toward visuals on charts or screens.
 
  Indicate whether the statement is true or false.

Question 2

Doing a speech quickly will help reduce your nervousness and cater to more peoples attention spans.
 
  Indicate whether the statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Bsand8

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

F

Answer to Question 2

F




jrubin

  • Member
  • Posts: 552
Reply 2 on: Jul 19, 2018
Excellent


ultraflyy23

  • Member
  • Posts: 312
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library